R. Nagaraja
发表
Hua Yang,
Fang Wang,
Zenon Konteatis,
2017,
Cancer discovery.
J. Teruya-Feldstein,
Kwok-Kin Wong,
M. V. Heiden,
2018
.
E. Hickey,
N. Moss,
Yancey D. Ward,
2012,
Bioorganic & medicinal chemistry letters.
Hua Yang,
Marvin B. Cohen,
B. Fan,
2020,
Clinical pharmacology in drug development.
S. Gross,
T. Roddy,
A. Olaharski,
2020,
Toxicology and applied pharmacology.
I. Mellinghoff,
Cheng Fang,
Hua Yang,
2020,
ACS medicinal chemistry letters.
W. Liu,
K. Marks,
S. Gross,
2021,
Cancer cell.
J. Teruya-Feldstein,
Kwok-Kin Wong,
M. V. Heiden,
2018,
The Journal of clinical investigation.
Younggi Choi,
N. Moss,
D. Skow,
2009,
Bioorganic & medicinal chemistry letters.
S. Choe,
S. Gross,
Giovanni Cianchetta,
2018,
Molecular and Cellular Biology / Genetics.
M. Kumar,
C. Nagaraja,
R. Nagaraja,
2019,
The Indian Journal of Animal Sciences.
K. Marks,
S. Gross,
B. Delabarre,
2021,
Journal of medicinal chemistry.
A pharmacogenomic approach validates AG-221 as an effective and on-target therapy in IDH2 mutant AML
L. Kats,
K. Yen,
R. Johnstone,
2017,
Leukemia.
Brandon Nicolay,
J. Murtie,
E. Aguado,
2017
.
I. Mellinghoff,
Hua Yang,
K. Yen,
2018
.
K. Marks,
J. Murtie,
Chi-Chao Chen,
2020
.
J. Teruya-Feldstein,
K. Yen,
M. V. Vander Heiden,
2018,
The Journal of clinical investigation.